Peter Y. Ji, Sandra C. Tseng, and Aseem Z. Ansari

Slides:



Advertisements
Similar presentations
Cell and Molecular Biology Behrouz Mahmoudi Cell cycle 1.
Advertisements

LECTURE 17: RNA TRANSCRIPTION, PROCESSING, TURNOVER Levels of specific messenger RNAs can differ in different types of cells and at different times in.
Molecular Biology Fifth Edition
Exon selection factor Exon selection factor U2 snRNPU1 snRNP Intron 1 Overview of mRNA Splicing Exon 1 AGGU Exon 2 A AGG Factors such as U1 and U2 snRNP.
Transcription. Transcriptiontion- the synthesis of RNA using DNA as a template. Four stages: Initiation, Elongation, Termination, Post-transcriptional.
Elongation and Termination of Transcription. Elongation phase of transcription Requires the release of RNA polymerase from the initiation complex Highly.
Biology 1060 Chapter 17 From Gene to Protein. Genetic Information Important: Fig Describe how genes control phenotype –E.g., explain dwarfism in.
Gene Expression and Gene Regulation. The Link between Genes and Proteins At the beginning of the 20 th century, Garrod proposed: – Genetic disorders such.
Phenotypic Characterization of lrb Mutants in Arabidopsis thaliana. Brandon D. Blaisdell 1, Matthew Christians 2, Derek J. Gingerich 1 1 Department of.
Chapter 17 From Gene to Protein
1 RNA processing enzymes are recruited by the tail of polymerase.
Lecture 10: Cell cycle Dr. Mamoun Ahram Faculty of Medicine
Colinearity of Gene and Protein
Molecular Biology Fifth Edition
RNA post-transcriptional processing
Chapter 14~ From Gene to Protein
Gene Activity How Genes Work.
Jaya Sahni, Andrew M. Scharenberg  Cell Metabolism 
Relationship between Genotype and Phenotype
Phosphoinositide 3-kinase inhibitors protect mouse kidney cells from cyclosporine- induced cell death  E. Sarró, O. Tornavaca, M. Plana, A. Meseguer, E.
by Rong Chen, Michael J. Keating, Varsha Gandhi, and William Plunkett
Volume 13, Issue 3, Pages (February 2004)
Quantitative Genetic Interactions Reveal Biological Modularity
Chapter 7 Messenger RNA.
Yan Jiang, Mingyi Liu, Charlotte A. Spencer, David H. Price 
Volume 68, Issue 1, Pages e5 (October 2017)
Sarah R. Gonzales-van Horn, Peter Sarnow  Cell Host & Microbe 
A DNA Damage Response Pathway Controlled by Tel1 and the Mre11 Complex
Volume 35, Issue 1, Pages 1-10 (July 2009)
10mM glucosamine prevents activation of proADAMTS5 (aggrecanase-2) in transfected cells by interference with post-translational modification of furin 
Volume 119, Issue 6, Pages (December 2004)
Volume 23, Issue 7, Pages e3 (May 2018)
RNA interference is essential for cellular quiescence
Volume 31, Issue 3, Pages (August 2008)
Phosphorylation of Serine 2 within the RNA Polymerase II C-Terminal Domain Couples Transcription and 3′ End Processing  Seong Hoon Ahn, Minkyu Kim, Stephen.
Annika Guse, Masanori Mishima, Michael Glotzer  Current Biology 
RNA interference is essential for cellular quiescence
Volume 19, Issue 2, Pages (July 2005)
Volume 133, Issue 3, Pages (May 2008)
Epigenetics modification
Antonin Morillon, Nickoletta Karabetsou, Anitha Nair, Jane Mellor 
Sarah R. Gonzales-van Horn, Peter Sarnow  Cell Host & Microbe 
Volume 17, Issue 1, Pages (January 2005)
Volume 20, Issue 5, Pages (December 2005)
Volume 22, Issue 3, Pages (January 2018)
Protein and RNA Export from the Nucleus
Claudia Schneider, James T. Anderson, David Tollervey  Molecular Cell 
Volume 23, Issue 2, Pages (July 2006)
Volume 55, Issue 5, Pages (September 2014)
Gene-Specific Regulation by General Translation Factors
Volume 20, Issue 5, Pages (August 2017)
A Biochemical Function for the Sm Complex
Volume 73, Issue 3, Pages e3 (February 2019)
Lecture #7 Date _________
Volume 30, Issue 4, Pages (May 2008)
Volume 61, Issue 2, Pages (January 2016)
Signaling to Chromatin through Histone Modifications
Ssu72 Is an RNA Polymerase II CTD Phosphatase
Yan Jiang, Mingyi Liu, Charlotte A. Spencer, David H. Price 
Regulation of Yeast mRNA 3′ End Processing by Phosphorylation
Marijn T.M. van Jaarsveld, Difan Deng, Erik A.C. Wiemer, Zhike Zi 
Jan H. Reiling, Kathrin T. Doepfner, Ernst Hafen, Hugo Stocker 
Vidhya Ramachandran, Khyati H. Shah, Paul K. Herman  Molecular Cell 
Volume 33, Issue 6, Pages (March 2009)
Volume 5, Issue 6, Pages (June 2000)
Volume 2, Issue 4, Pages (October 2012)
Volume 15, Issue 16, Pages (August 2005)
Relationship between Genotype and Phenotype
Volume 9, Issue 5, Pages (May 2002)
No Driver behind the Wheel? Targeting Transcription in Cancer
Presentation transcript:

Peter Y. Ji, Sandra C. Tseng, and Aseem Z. Ansari Rai1 depletion does not restore viability in yeast in kin28 defective strains Peter Y. Ji, Sandra C. Tseng, and Aseem Z. Ansari UW Department of Biochemistry, University of Wisconsin-Madison Background Kin28is kinase inhibition retards cell growth ∆Rai1 shows depletion of global mRNA in CMK treated cells. Kin28, an enzyme that possesses many roles in DNA transcription, initiates the elongation phase of polymerase II and recruits capping enzymes to process nascent RNA shortly after RNA transcripts are produced (1). These activities are achieved through the phosphorylation of residues on the carboxyl-terminal domain (CTD) of polymerase, a large subunit that undergoes many modifications throughout transcription (2). Although the requirement of kin28 in efficient transcription is not proven, chemical inhibition of kin28 decreases the growth rate of yeast in kin28-analog sensitive strains (Tseng et. al, 2012). Since the loss of kin28 function may cause a decrease in overall transcriptional activity, we wished to explore an approach to synthetic rescue through restoring transcriptional efficiency. Synthetic rescue was attempted by testing genetically modified strains that lacked an exonuclease, Rai1, when kin28-inhibited (3). These results demonstrate that kin28 function cannot be dispensed by the removal of exonuclease Rai1. A +CMK B +DMSO Rai1 kin28is ∆Rai1 kin28is ∆Rai1 WT ∆Rai1 AS ∆Rai1 IS Kin28 WT Kin28 AS Kin28 IS B DMSO 1-NAPP-1 CMK Drop test of kin28 WT, as, is strains showed less growth following CMK and 1-NAPP-1 treatment to DMSO control. Exonuclease dropout did not result in significant cell rescue in CMK treated cells. ∆Rai1 kin28 WT, as, is strains are less healthy than w/ Rai1 strains, regardless of kinase inhibition. mRNA expression levels were normalized against DMSO levels in ∆Rai1 and w/ Rai1 strains. B) Relative levels of mRNA were unaffected/not raised by the lack of Rai1 upon inhibition in kin28is strains. mRNA was substantially depleted by kin28 inhibition in both ∆Rai1 and kin28is strains. Recovery of mRNA in Hsp12, significantly in 1-NAPP-1, may be an experimental error. Graphs of optical density from 0 to 25 minutes. A) kin28is grown in control (DMSO), reversible inhibitor 1-NAPP-1 and irreversible inhibitor CMK. Addition of CMK potently sequesters cell growth. Doubling times of kin28is of OD600 from initial OD of 0.2 were 3.9 minutes and 5.0 min for DMSO and 1-NAPP-1 respectively. B) The same methods were applied as kin28is with the ∆Rai1 mutation. Mutants showed decreased cell growth and growth phase initiation. In DMSO control, mutants had a 5.8 minute doubling time, compared to 3.9 minutes in non-mutant kin28is. Application of reversible 1-NAPP-1 drastically hindered cell division to a doubling time of 17 minutes. This suggests that ∆Rai1 knockouts contribute to a low-growth phenotype especially under conditions of kin28 deprivation through the accumulation of uncapped RNA transcripts. ∆Rai1 kin28is Kin28is Growth curve of ∆Rai1 kin28is reveals longer growth initiation Conclusions A B ∆Rai1 neither restores amounts of stable transcripts nor results in synthetic rescue Global mRNA levels in ∆Rai1 kin28is over kin28is do not increase in +CMK cells. Kin28 function is important in transcriptional and translational efficiency. Decrease in cell viability couples with low transcriptional efficiency in kinase-inhibited yeast. The 5’-end methylguanosine cap and its recruitment by kin28 relates to mRNA transcriptional success and cell viability. DMSO 1-NAPP-1 CMK DMSO 1-NAPP-1 CMK Kin28 phosphorylates Ser5 and Ser7 on the CTD at the transcription start site on hypophosphorylated RNA Polymerase II, stimulating transcription and the recruitment of other CTD kinases. (Adapted from Hinnebusch et al., 2012) kin28 Pol II m7Gppp cap mRNA Rai1 A) Kin28 recruits a capping complex onto nascent mRNA via Ser5-P marks on the CTD. The 5’end cap protects mRNA from exonuclease degradation. B) kin28 inhibition results in the action of Rai1, an exonuclease that acts quickly after RNA synthesis to degrade uncapped mRNA transcripts. A B Further Directions Analyze nascent RNA for levels of m7G capped transcripts in relation to degree of kin28is inhibition using western blotting. Analyze the efficiency of Rai1 mRNA degradation in kin28-inhibited strains by residual levels of un-capped transcripts. Measure the accumulation rate of incompletely capped mRNA in ∆Rai1, +CMK kin28is strains by comparison of nascent RNA levels against global RNA. References: Rodriguez CR; Cho EJ; Keogh MC. Mol Cell Biol. 2000 Jan;20(1):104-12. Søgaard TM; Svejstrup JQ. J Biol Chem. 2007 May 11;282(19):14113-20. Epub 2007 Mar 21. Zhai LT; Xiang S. J Zhejiang Univ Sci B. 2014 May;15(5):438-43.